Studies have shown that interleukin-2 (IL-2) and the downstream transcription factor STAT5 are essential for maintaining regulatory T (Treg) cell homeostasis and function (Cheng et al., 2018), suggesting that the immune microenvironment in tumor tissue of PAAD patients affected by somatic mutations may be disrupted. This evidence concerns the gene IL2 and neoplasm.